Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Attachment of 2-Pyridyltetrazine Affinity Bioorthogonal Chemistry (ABC) Tags to Proteins for Site-Selective Bioorthogonal Chemistry.

Created on 02 Aug 2026

Authors

Paramesh K Ramaraj, Samuel L Scinto, Joseph M Fox

Published in

Methods in molecular biology (Clifton, N.J.). Volume 3009. Pages 177-196.

Abstract

Site-selective labeling of proteins with small molecules can be performed by using different chemical and enzymatic methods. However, many of these methods lead to incomplete conversion or side products resulting in a mixture where the desired product may be inseparable. Herein, we present a protocol for the site selective conjugation of 3-methyl-6-(2-pyridyl)tetrazine to proteins. 3-methyl-6-(2-pyridyl)tetrazine, in addition to serving a bioorthogonal reagent capable of reacting to strained alkenes such as trans-cyclooctene, also functions as an affinity tag due to its ability to bind to nickel immobilized on resin. This Affinity Bioorthogonal Chemistry (ABC) tag enables the separation of the conjugated product from the unreacted starting material and any side products that may form during the conjugation reaction. This protocol describes the synthesis of the required 3-methyl-6-(2-pyridyl)tetrazines for conjugation to proteins, and the subsequent conjugation and purification steps required for obtaining ABC-tag functionalized protein.

PMID:
42542488
Bibliographic data and abstract were imported from PubMed on 02 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement